Dec 12, 1999
| By Gayle Gerling Pettinga
| Read Time: < 1 minute
December 1999 – Taxotere was approved as an injection to treat patients suffering from locally advanced or metastatic non-small cell lung cancer following failure of prior platinum-based chemotherapy.
Reference: “FDA Approves New Taxotere® (Docetaxel) Injection Concentrate Formulation – Aug 5, 2010.” Sanofi, www.news.sanofi.us/press-releases?item=118530
Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.
Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.